Medication acceptance and adherence are critical concerns in pediatric populations due to these patients’ rapid anatomical and physiological development. Additionally, vastly different pharmacokinetics and pharmacodynamics apply when moving through growth stages from neonates to adolescents.
This diversity — combined with a limited market size, a complex formulation process, and stringent regulation — makes the design and development of patient-centric pediatric formulations challenging.
